About the reality that his nation is now experiencing increasing outbreaks that are stretching hospitals and much more than 1,000 people are going to die every week from the epidemic, France’s president claims he has no remorse for declining to enforce a third virus lockout earlier this year.
As the pandemic begins its second year, President Emmanuel Macron’s administration has highlighted the value of holding kids in school and enterprises intact.
Table of Contents
- Some Medical Professionals Ask For Stricter Restrictions
- Norway Stall On Vaccine Decision
- Vaccines On Hold Due To Safety Concerns
- Sixth Person To Die After Receiving Vaccine
“We were correct not to impose a lockout in France at the end of January although we did not have the flood of cases that any model expected,” he said late on Thursday night at the conclusion of an EU summit. “I’m not going to apologize for anything. I feel no regrets over my behavior and refuse to accept responsibility for my mistakes. “
France has been advocating for a “third path” between imprisonment and liberty for months, involving a national curfew and the closure of hotels, libraries, cinemas, gyms, several shopping centers, and other companies.
Some Medical Professionals Ask For Stricter Restrictions
Many medical professionals have been advising the French government to introduce stricter restrictions for weeks, citing the more infectious and deadly virus strain that was first detected in the United Kingdom and is now prevalent in France.
“There is no such thing as a virus-free setting, and this is valid for any nation in Europe. We are not an island, and even the islands that have effectively secured themselves have seen the virus resurface on occasion, “Macron claimed following. “However, we felt that with the curfew and other steps in effect, we would be able to cope.”
With 93,378 lives lost, France has the fourth-largest number of virus outbreaks in the country, as well as one of the highest death tolls. Because of a recent influx of seriously sick virus patients, intensive care units in Paris and many other regions are once again near or above capacity.
Norway Stall On Vaccine Decision
According to unnamed sources cited by TV2, Norway will postpone a decision about whether to resume using AstraZeneca’s COVID-19 vaccine.
Since a limited number of younger inoculated individuals were treated with a mixture of blood clots, swelling, and a reduced platelet count, officials postponed the vaccine’s introduction two weeks ago. Some of the people who were hospitalized eventually died.
The duration of the delay was not specified in the TV2 survey.
The Norwegian Institute of Public Health, that is set to release its judgment at 1200 CET (1100 GMT), refused to speak on the TV2 story via a spokeswoman.
Vaccines On Hold Due To Safety Concerns
Norway is one of more than a dozen European countries that has placed the vaccine on hold due to safety issues, though most countries have since started using it based on the European Medicines Agency’s recommendation (EMA).
The effects of the shot in preventing coronavirus-related mortality or hospitalization, according to the EMA, outweighed any potential dangers. The vaccination has also obtained funding from the International Health Organisation.
An analysis of safety results from more than 17 million individuals inoculated with AstraZeneca’s vaccine in the United Kingdom and the European Union found no signs of an elevated risk of blood clots, according to the company.
Five individuals in Norway have been hospitalized since getting the AstraZeneca vaccine, three of whom have died, leading to a mixture of blood clots, swelling, and insufficient platelets.
Sixth Person To Die After Receiving Vaccine
According to health officials, a sixth individual who received the vaccine died from a brain haemorrhage combined with a reduced platelet count.
Norway has been utilizing vaccines produced by Pfizer/BioNTech and Moderna, with the intention of moving to Johnson & Johnson’s until stocks become accessible in Europe.
Since Sweden buys more vaccinations than it wants and then passes them on to its neighbor, the non-EU nation receives the vaccines through the European procurement programme.
Since the beginning of the pandemic early last year, Norway has seen some of Europe’s lowest rates of illnesses and fatalities, but is still experiencing a rapid uptick in hospitalizations due to increasingly infectious virus types.